| no |
title |
author |
magazine |
year |
volume |
issue |
page(s) |
type |
| 1 |
Another crackdown on LGBTQ+ people in Africa
|
The Lancet HIV,
|
|
|
11 |
5 |
p. e273
|
article
|
| 2 |
Associations between change in BMI and the risk of hypertension and dyslipidaemia in people receiving integrase strand-transfer inhibitors, tenofovir alafenamide, or both compared with other contemporary antiretroviral regimens: a multicentre, prospective observational study from the RESPOND consortium cohorts
|
Byonanebye, Dathan M
|
|
|
11 |
5 |
p. e321-e332
|
article
|
| 3 |
Collective antiretroviral protection: new dimensions of community HIV prevention practices at the intersection of U=U and PrEP
|
Brisson, Julien B
|
|
|
11 |
5 |
p. e341-e344
|
article
|
| 4 |
DNA and protein HIV vaccines: how should we mix it?
|
Levy, Yves
|
|
|
11 |
5 |
p. e274-e275
|
article
|
| 5 |
Enhancing HIV care with incentives: one size does not fit all
|
McCoy, Sandra I
|
|
|
11 |
5 |
p. e277-e278
|
article
|
| 6 |
Expanding options of child-friendly, single-tablet regimens for young children with HIV
|
Cressey, Tim R
|
|
|
11 |
5 |
p. e275-e276
|
article
|
| 7 |
Highlights from CROI 2024
|
Hayward, Peter
|
|
|
11 |
5 |
p. e284
|
article
|
| 8 |
HIV at a crossroads in Pakistan
|
Raza, Hussain A
|
|
|
11 |
5 |
p. e283
|
article
|
| 9 |
Intersectional climate justice, health equity, and HIV
|
Wilson, Sarah M
|
|
|
11 |
5 |
p. e280-e281
|
article
|
| 10 |
Low-cost urine tenofovir assay to triage dolutegravir resistance testing
|
Martinson, Tyler
|
|
|
11 |
5 |
p. e282-e283
|
article
|
| 11 |
More pressure on integrase strand-transfer inhibitors?
|
Pozniak, Anton L
|
|
|
11 |
5 |
p. e278-e280
|
article
|
| 12 |
Non-suppressible viraemia during HIV-1 therapy: a challenge for clinicians
|
Esteban-Cantos, Andrés
|
|
|
11 |
5 |
p. e333-e340
|
article
|
| 13 |
Pharmacokinetics and safety of coformulated bictegravir, emtricitabine, and tenofovir alafenamide in children aged 2 years and older with virologically suppressed HIV: a phase 2/3, open-label, single-arm study
|
Rodriguez, Carina A
|
|
|
11 |
5 |
p. e300-e308
|
article
|
| 14 |
Safety and immunogenicity of a polyvalent DNA–protein HIV vaccine with matched Env immunogens delivered as a prime–boost regimen or coadministered in HIV-uninfected adults in the USA (HVTN 124): a phase 1, placebo-controlled, double-blind randomised controlled trial
|
Frank, Ian
|
|
|
11 |
5 |
p. e285-e299
|
article
|
| 15 |
Voucher incentives to improve viral suppression among HIV-positive people who inject drugs and men who have sex with men in India: a cluster randomised trial
|
Solomon, Sunil S
|
|
|
11 |
5 |
p. e309-e320
|
article
|
Journal description